Profil
Tyler Marciniak is SVP-Investor Relations & Corporate Communications at Transcenta Holding Ltd. since 2025.
Former roles include Director-Oncology Communications & Advocacy at Astellas Pharma, Inc. and VP-Investor Relations, Media & Operation at ACELYRIN, Inc. Education includes graduate studies at The Trustees of Columbia University in The City of New York and an MBA from Kellogg School of Management.
Postes actifs de Tyler Marciniak
| Sociétés | Poste | Début |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Investor Relations Contact | 16/10/2025 |
Anciens postes connus de Tyler Marciniak
| Sociétés | Poste | Fin |
|---|---|---|
| ACELYRIN, INC. | Investor Relations Contact | 21/05/2025 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - |
Formation de Tyler Marciniak
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma, Inc.
Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transcenta Holding Ltd.
Transcenta Holding Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that manufactures and wholesales pharmaceutical products | Health Technology |
ACELYRIN, Inc.
ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
















